Page 1

Laurus Labs Limited Corporate Office 2nd Floor , Serene Chambers , Road No. 7 Banjara Hills , Hyderabad - 500034 , Telangana , India T +91 40 6659 4333 , 3980 4333 , 2342 0500/501 F +91 40 6659 4320/3980 4320 LAURUS Labs Knowledge . Innovation . Excellence October 28 , 2021 To The Corporate Relations Department BSE Limited Phiroz Jeejeebhoy Towers , 25th Floor , Dalal Street Mumbai 400001 Code : 540222 Dear Sirs , To The Listing Department National Stock Exchange of India Limited Exchange Plaza , Bandra Kurla Complex , Bandra ( East ) Mumbai 400 051 Code : LAURUSLABS Sub : Approval of unaudited Financial Results for the Quarter and Half year ended September 30 , 2021 : Pursuant to Regulation 33 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , the Board of Directors have approved the unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended September 30 , 2021 at their meeting held on October 28 , 2021 , which are enclosed herewith along with the Limited Review Reports issued by Deloitte Haskins & Sells LLP , the Statutory Auditors of the Company . The financial results are also available on the website of the Company at www.lauruslabs.com and also on the websites of BSE Ltd. and National Stock Exchange of India Ltd. viz . www.bseindia.com and www.nseindia.com respectively . The Board Meeting commenced at 2.00 PM and concluded at 3.00 PM . This is for your information and records . Thanking you , Yours sincerely , For Laurus Labs Limited G. Venkateswar Reddy Company Secretary Encl : As above US URU LABS Hyderabad LIMITED Registered Office : Plot No : 21 , Jawaharlal Nehru Pharma City , Parawada , Visakhapatnam - 531021 , Andhra Pradesh , India . CIN : L24239AP2005PLC047518 T +91 891 660 1222 , 306 1222 , F +91 891 660 1270 ; 306 1270 , E info@lauruslabs.com W lauruslabs.com LAURUS Generics API & Formulations LAURUS Synthesis Contract Development & Manufacturing Services LAURUS Bio Biotechnology